Explore

AP News AP News
The condition PCOS is now called PMOS. What to know about the name change and what it means for care

The condition PCOS is now called PMOS. What to know about the name change and what it means for care

A hormonal condition affecting 1 in 8 women around the world just got a new name in hopes of improving care
Trendline Trendline
PCOS Renamed to PMOS to Reflect Complex Nature of Condition

PCOS Renamed to PMOS to Reflect Complex Nature of Condition

PCOS Renamed to PMOS to Reflect Complex Nature of Condition
Rapid Read Rapid Read
Global Effort Renames PCOS to PMOS, Offering New Hope for Women

Global Effort Renames PCOS to PMOS, Offering New Hope for Women

After more than a decade of global consultation, polycystic ovary syndrome (PCOS) has been renamed polyendocrine metabolic ovarian syndrome (PMOS). This change, announced at the European Congress of Endocrinology, aims to better reflect the condition's complex nature, which affects not only reproductive health but also metabolism and cardiovascular risk. The renaming effort was led by endocrinologist Prof. Helena Teede and involved collaboration with international societies and patient groups. The new name addresses the misleading focus on ovarian cysts and highlights the broader hormonal and metabolic implications of the condition.
Rapid Read Rapid Read
PCOS Officially Renamed PMOS to Reflect Broader Health Implications

PCOS Officially Renamed PMOS to Reflect Broader Health Implications

Polycystic ovary syndrome (PCOS) has been officially renamed polyendocrine metabolic ovarian syndrome (PMOS) to better reflect the condition's complex nature. Announced at the European Congress of Endocrinology, the name change addresses misconceptions about the condition, which affects one in eight women. The new name highlights the metabolic and hormonal dimensions of the syndrome, moving away from the misleading focus on ovarian cysts. This change is part of a broader effort to improve understanding and treatment of the condition, which can lead to symptoms such as irregular periods, acne, and insulin resistance.
Rapid Read Rapid Read
Global Experts Rename PCOS to Reflect Its Multisystem Nature

Global Experts Rename PCOS to Reflect Its Multisystem Nature

Polycystic ovary syndrome (PCOS) has been officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) following a global consensus study. This change reflects the condition's complexity, involving endocrine, metabolic, reproductive, dermatological, and psychological health. The new name aims to address the inaccuracies of the previous term, which often led to misconceptions and stigma, particularly around fertility. The renaming is expected to reshape how the condition is diagnosed, treated, and researched globally, promoting earlier and more accurate diagnosis and supporting holistic, patient-centered care.
Trendline Trendline
Avenacy Launches Ready-to-Use Tranexamic Acid Injection in U.S. Market

Avenacy Launches Ready-to-Use Tranexamic Acid Injection in U.S. Market

Avenacy Launches Ready-to-Use Tranexamic Acid Injection in U.S. Market
Discover daily Discover daily
Pennsylvania Hospital Opened a Lying-In Department in 1803

Pennsylvania Hospital Opened a Lying-In Department in 1803

Pennsylvania Hospital has been a trailblazer in the field of women's medicine, particularly in maternity care. From its early establishment of a ma...
Rapid Read Rapid Read
SQ Innovation's At-Home Treatment for Heart Failure Edema Shows Promising Results in Trial

SQ Innovation's At-Home Treatment for Heart Failure Edema Shows Promising Results in Trial

SQ Innovation has announced the results of the SUBCUT HF II trial, which evaluated the efficacy and safety of Lasix ONYU, a subcutaneous formulation of furosemide, for treating edema in heart failure patients at home. The trial involved 172 patients, with 92 receiving at-home treatment and 80 receiving standard in-hospital intravenous diuretics. The study found that patients treated at home spent an average of four fewer days in the hospital compared to those receiving traditional care. The trial met its primary endpoint of reducing hospital days, demonstrating that at-home treatment is both effective and safe. The results were presented at the Heart Failure 2026 congress in Barcelona.
AP News AP News
By changing women's lives, the pill changed the nation

By changing women's lives, the pill changed the nation

The pill helped give birth to modern America
Trendline Trendline
Optum Rx Introduces Transparent PBM Model to Enhance Cost Clarity for Clients

Optum Rx Introduces Transparent PBM Model to Enhance Cost Clarity for Clients

Optum Rx Introduces Transparent PBM Model to Enhance Cost Clarity for Clients
Trendline Trendline
Healthcare Industry Faces $262 Billion in Denied Claims, Calls for Systemic Change

Healthcare Industry Faces $262 Billion in Denied Claims, Calls for Systemic Change

Healthcare Industry Faces $262 Billion in Denied Claims, Calls for Systemic Change
Rapid Read Rapid Read
Dr. Emily Steier's Aliyah to Jerusalem Amid Wartime Challenges

Dr. Emily Steier's Aliyah to Jerusalem Amid Wartime Challenges

Dr. Emily Steier, a fourth-generation medical professional, made aliyah to Jerusalem in December 2023, amidst the backdrop of war and uncertainty. Originally settled in the United States, Steier and her husband decided to move to Israel after feeling a strong calling to raise their children in a culture that supports their Jewish identity. Despite the challenges posed by the ongoing conflict, including sirens and missile threats, the family adapted to their new environment. Steier, a psychiatrist, has integrated into Israel's healthcare system, working with Meuhedet in Jerusalem and treating patients dealing with trauma and anxiety. Her journey reflects a commitment to building a life in Israel, overcoming linguistic and cultural barriers, and establishing a private practice focused on women's mental health.